M. Scot Roberts - 31 Jul 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Scientific Officer
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
31 Jul 2023
Transactions value $
$1,596
Form type
4
Filing time
02 Aug 2023, 17:47:21 UTC
Previous filing
06 Feb 2023
Next filing
29 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $1.6K +568 +2.86% $2.81 20.4K 31 Jul 2023 Direct F1, F2
holding ALT Common Stock, par value $0.0001 15 31 Jul 2023 Shares held by spouse of Reporting Person
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2023 through July 31, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2023.